Endothelin-receptor antagonists in the management of pulmonary arteria | VHRM
Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension - Kazuya Miyagawa, Noriaki Emoto, 2014
Endothelin and endothelin antagonists in chronic kidney disease - ScienceDirect
Bosentan - Endothelin blocker - YouTube
Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism - ScienceDirect
The Endothelin System and Its Antagonism in Chronic Kidney Disease | American Society of Nephrology
Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening | SpringerLink
Endothelin Receptor Blockers in Cardiovascular Disease | Circulation
Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION | tctmd.com
Endothelin antagonists - The Lancet
CV Physiology | Endothelin
Pharmacological and therapeutic properties of new derivatives of renin inhibitors and endothelin receptor antagonists, and the methods of their determ ... - Analytical Methods (RSC Publishing) DOI:10.1039/C5AY00651A
Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve? - ScienceDirect
Endothelin receptor antagonists in pulmonary arterial hypertension | European Respiratory Society
Nonpeptide endothelin receptor antagonists and their relative... | Download Scientific Diagram
JCM | Free Full-Text | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
The Endothelin System | Encyclopedia MDPI
Endothelin | Pharmacological Reviews
Dual endothelin receptor antagonism increases resting energy expenditure in people with increased adiposity | American Journal of Physiology-Endocrinology and Metabolism
Endothelins | NEJM
Emerging role of endothelin-1 in tumor angiogenesis: Trends in Endocrinology & Metabolism
JCM | Free Full-Text | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
Endothelin | Pharmacological Reviews
